Our Work
Supporting the development of tomorrow's vaccines
Our work
EVI recognises the power of partnerships and engages with partners worldwide to harness the best knowledge and expertise from leaders in the field of vaccine R&D. We aim to spearhead global vaccine development efforts by engaging with partners from academia and other research institutions, the private sector, governments and civil society organisations, including partners from low- and middle-income countries affected by diseases of poverty.
EVI´s activities are diverse. EVI supports and coordinates research into individual vaccine candidates, works across Europe to harmonise processes and protocols for vaccine development, and to build capacity, and EVI supports the strengthening of capacity for vaccine Research and Development (R&D) in low- and middle-income countries.
Our proven track record
EVI has supported the development of more than thirty vaccine formulations, seventeen of which have progressed into early clinical development. Three candidates transitioned to partners for mid-stage clinical development.
EVI has further provided services (i.e., preclinical evaluation, research for biomarkers) to support the advancement of another 29 vaccine projects including, but not restricted to, dengue, mumps, tuberculosis, pertussis, melanoma, HIV, ovarian carcinoma and malaria vaccine candidates as well as novel adjuvants.
EVI has also supported the establishment the first control human challenge model of paratyphoid infection. In more than 20 years of existence, EVI has built long-lasting partnerships with vaccine scientists from across the globe, including Europe, the USA, India, Japan, as well as Burkina Faso, Kenya, Ethiopia, Senegal, Gambia, allowing us to cooperate in the strategy and decision-making processes of partner organisations and identifying and recruiting the best ad-hoc experts to advise and lead the development of vaccines.
Due to its existing expertise, EVI is perfectly placed to support the development of badly needed life-saving vaccines.
Dr. Sodiomon Bienvenu Sirima
Researcher at Groupe de Recherche
Action en Santé, Burkina Faso
Our strengths
Project
management
Advocacy & Communication
Network
management
Operational
R&D support
Coordinating multinational projects
Successful project proposals, administrative support,
strategic and effective coordination of research projects across all stages.
Disseminating science beyond the lab
Partners, stakeholders, and the public.
Harnessing the power of alliances
Strategic partnerships, engaging the best knowledge and expertise to build multidisciplinary and international consortia.
Supporting research across all development stages
Manufacturing process, preclinical testing and clinical trial management, subcontracting management and regulatory support including scientific advice preparation.